A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B
A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B
Active, not recruiting · NCT07203118 · Registry updated 2025-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase II/III of Hepenofovir Fumarate Tablets (HTS) for Chronic Hepatitis B | Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic hepatitis B virus infection, hepatitis, hepatitis B virus infection, infectious disease, liver disorder, viral hepatitis, viral infectious disease | Active, not recruiting | Phase 2 / Phase 3 | 2025-10-02 | NCT07203118 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Xi'an Xintong Pharmaceutical Research Co.,Ltd. | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The first hospital of Jilin University | Jilin City | China | 4 |